title: [Bacteriology of community-acquired peritonitis in children treated in the university hospital of Marrakech].
abstract: BACKGROUND
  The available microbiological data on community-acquired peritonitis in children are inadequate, and antibiotic therapy is not consensual. Our work aims to study the bacteriology of peritonitis in children in our region and discuss the appropriate antibiotherapy.
  
  
  METHODS
  A descriptive study spread over one year. We collected cases of peritonitis in which a microbiological study of peritoneal fluid was performed.
  
  
  RESULTS
  Of 38 cases, the most frequently isolated bacteria is Escherichia coli (E. coli) (50%). Its sensitivity was 64% to amoxicillin-clavulanate, 93.33% to third generation cephalosporins (C3G) and 100% to ertapenem and aminozides.
  
  
  CONCLUSIONS
  We find a high rate of resistance of E. coli to amoxicillin-clavulanic acid. This prompts us to reconsider our therapeutic approach. We believe that the association C3G+aminoglycoside+metronidazole should be used first-line in the pediatric peritonitis in our context.
authors.affiliation: Service d'anesthésie-réanimation pédiatrique, hôpital Mère-Enfant, CHU Mohammed VI, université Cadi Ayyad, rue Ibn Sina, Amerchich, Marrakech, Maroc.
authors.forename: Y
authors.initials: Y
authors.lastname: Mouaffak
authors.forename: M
authors.initials: M
authors.lastname: Boutbaoucht
authors.forename: N
authors.initials: N
authors.lastname: Soraa
authors.forename: L
authors.initials: L
authors.lastname: Chabaa
authors.forename: T
authors.initials: T
authors.lastname: Salama
authors.forename: M
authors.initials: M
authors.lastname: Oulad Saiad
authors.forename: S
authors.initials: S
authors.lastname: Younous
mesh_terms: D000293:Adolescent; D000900:Anti-Bacterial Agents / Q000494:pharmacology / Q000627:therapeutic use; D001202:Ascitic Fluid / Q000382:microbiology; D002511:Cephalosporins / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D017714:Community-Acquired Infections / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*; D004927:Escherichia coli Infections / Q000188:drug therapy / Q000382:microbiology; D005260:Female; D006785:Hospitals, University; D006801:Humans; D007223:Infant; D008297:Male; D008795:Metronidazole / Q000627:therapeutic use; D008826:Microbial Sensitivity Tests; D009018:Morocco / Q000453:epidemiology; D010538:Peritonitis / Q000188:drug therapy / Q000453:epidemiology / Q000382:microbiology*
chemical_list: D000900:Anti-Bacterial Agents; D002511:Cephalosporins; D008795:Metronidazole